Addison disease, also called primary adrenal insufficiency, is a disorder in which the adrenal cortex fails to produce adequate cortisol, often with deficient aldosterone. The resulting hormonal imbalance drives a characteristic constellation of symptoms—fatigue, weight loss, hypotension, hyperpigmentation, and electrolyte abnormalities—through loss of glucocorticoid permissive effects on metabolism and vascular tone, and—when present—mineralocorticoid-related sodium wasting.
Core mechanism and physiology
The adrenal cortex is responsible for steroidogenesis via cholesterol substrate conversion into cortisol (zona fasciculata) and aldosterone (zona glomerulosa). In primary adrenal insufficiency, the intrinsic adrenal gland damage or destruction reduces ACTH-regulated cortisol synthesis. In many cases, autoimmune adrenalitis is the predominant etiology, where immune-mediated injury progressively destroys steroid-producing cells. Cortisol deficiency leads to impaired hepatic gluconeogenesis and altered glucose homeostasis, increased susceptibility to hypoglycemia, and reduced vascular responsiveness to catecholamines. Meanwhile, loss of cortisol increases CRH and ACTH drive; ACTH’s shared precursor pro-opiomelanocortin yields higher melanocyte-stimulating activity, producing hyperpigmentation.
Clinical manifestations
Symptoms typically evolve subacutely but may present acutely as adrenal crisis. Common features include chronic fatigue, muscle weakness, anorexia, nausea, abdominal pain, and weight loss. Orthostatic hypotension and dizziness occur due to decreased intravascular volume and impaired vascular tone. When aldosterone is deficient, patients develop salt craving, hyponatremia, hyperkalemia, and metabolic acidosis tendencies. Laboratory patterns often reveal elevated ACTH, low morning cortisol, and deranged electrolytes. Physical findings can include hyperpigmented skin and mucosal darkening, particularly in creases, scars, and pressure points.
Adrenal crisis: medical urgency
Adrenal crisis is a life-threatening decompensation characterized by severe hypotension, dehydration, vomiting/diarrhea, abdominal pain, confusion, and sometimes fever or shock. Triggers include infection, surgery, trauma, missed glucocorticoid doses, or physiologic stress. The pathophysiology reflects acute insufficiency of cortisol needed to maintain blood pressure, vascular integrity, and stress adaptation. Prompt recognition and treatment are essential to reduce morbidity and mortality.
Etiologies and risk factors
Autoimmune adrenalitis accounts for a large proportion of primary adrenal insufficiency, frequently associated with other autoimmune endocrinopathies such as type 1 diabetes, autoimmune thyroid disease, and hypoparathyroidism (polyglandular autoimmune syndromes). Other causes include metastatic infiltration, infections (e.g., tuberculosis and endemic mycoses), hemorrhage (including Waterhouse-Friderichsen syndrome), genetic forms of adrenal steroidogenesis defects, and adrenalectomy.
Diagnosis: targeted endocrine testing
Initial evaluation includes assessment of symptoms, vitals (including orthostatic changes), and serum chemistries. A key step is measuring an early-morning serum cortisol level (often around 8 a.m.) and plasma ACTH. Low morning cortisol with elevated ACTH supports primary adrenal insufficiency. Confirmation relies on an ACTH (cosyntropin) stimulation test: cortisol is measured before and after synthetic ACTH administration. Inadequate cortisol rise indicates adrenal cortical insufficiency. Electrolyte panels typically demonstrate hyponatremia and hyperkalemia in aldosterone deficiency; mild anemia and eosinophilia can also be seen.
Further evaluation
After confirmation, clinicians should determine etiology. Autoimmune screening may include testing for adrenal 21-hydroxylase antibodies. Additional evaluation for coexisting autoimmune disorders includes thyroid function tests and diabetes assessment. Imaging (CT/MRI) is used when infiltrative, infectious, or hemorrhagic causes are suspected.
Evidence-based treatment
Long-term management centers on physiologic hormone replacement. Glucocorticoid therapy is essential—commonly hydrocortisone, prednisone, or prednisolone—tailored to symptom control and minimizing both over-replacement (weight gain, bone loss, metabolic effects) and under-replacement (fatigue, hypotension). If aldosterone deficiency is present, mineralocorticoid replacement with fludrocortisone is used, with monitoring of blood pressure, electrolytes, and renin levels.
Stress dosing and patient safety
Patients require education on stress dosing: increasing glucocorticoid during febrile illness, surgery, or significant injury to prevent adrenal crisis. They should be equipped with an emergency injection plan (e.g., intramuscular hydrocortisone) when oral intake is not possible. Wearable medical identification and clear sick-day rules reduce delays in emergency care.
Monitoring and prognosis
Regular follow-up includes blood pressure, weight, electrolytes (sodium, potassium), glucose, and clinical symptom review. For autoimmune disease, periodic screening for associated autoimmune endocrinopathies is recommended. When treated promptly and consistently, prognosis improves substantially; however, the risk of adrenal crisis persists if replacement is interrupted, during intercurrent illness, or without appropriate stress dosing.
Source: Creator (@DaschaTsaryova) via the provided source post.
Даша: Real talk — $CHANCE is only 100 votes away from getting listed on Moonshot Been loading up — once this lists it’s going to rip Don’t sleep on this and vote asap 👇. #breaking
— @DaschaTsaryova May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
